Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants
Applications

Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants

4 min read

High pressure homogenization is the core manufacturing […]

High pressure homogenization is the core manufacturing technology for leading vaccine adjuvants, including MF59 (Fluad), AS03 (Pandemrix), and liposomal adjuvant systems. The ability to produce stable oil-in-water nanoemulsions with consistent droplet size (< 200 nm) makes HPH indispensable for adjuvant manufacturing.

This guide covers the formulation, process, and scale-up of vaccine adjuvants using HPH.

Why Adjuvants Need High Pressure Homogenization

Nanotechnology high pressure homogenizer for advanced vaccine adjuvant formulation and delivery
Nanotechnology-enabled high pressure homogenization for vaccine adjuvant and liposome manufacturing
Vaccine adjuvants are formulated to enhance the immune response to antigens. For emulsion-based adjuvants, the droplet size directly affects:

  • Antigen adsorption: Larger surface area at smaller droplet sizes
  • Immune stimulation: Submicron droplets are more effectively taken up by antigen-presenting cells
  • Stability: Uniform droplet size prevents creaming and coalescence
  • Injectability: Submicron emulsions pass through fine-gauge needles easily

The gold standard ? MF59 ? uses high pressure homogenization to produce squalene-in-water nanoemulsion droplets of approximately 160 nm.

Types of Emulsion Adjuvants

MF59 (Novartis/Seqirus)

  • Composition: Squalene (oil), Tween 80, Span 85 in citrate buffer
  • Droplet size: ~ 160 nm
  • Homogenization: High pressure homogenizer, 500?1000 bar, 3?5 passes
  • Used in: Fluad (seasonal influenza vaccine for elderly)

AS03 (GSK)

  • Composition: Squalene, ?-tocopherol, Tween 80 in PBS
  • Droplet size: ~ 150?180 nm
  • Homogenization: HPH, 600?1000 bar
  • Used in: Pandemrix, Arepanrix (H1N1 pandemic vaccines)

AS04 (GSK)

  • Composition: Aluminum salt + MPL (not emulsion ? adjuvant system)
  • Note: Not emulsion-based

AS01 (GSK)

  • Composition: Liposomal formulation with MPL and QS-21
  • Homogenization: HPH used for liposome manufacturing step
  • Used in: Shingrix (shingles vaccine), Mosquirix (malaria vaccine)

Manufacturing Process for Emulsion Adjuvants

Step 1: Aqueous Phase Preparation

Buffer solution (citrate or phosphate) prepared with Tween 80. Filtered through 0.2 ?m filter.

Step 2: Oil Phase Preparation

Squalene (and ?-tocopherol for AS03-type) mixed with Span 85. Gentle heating if needed.

Step 3: Coarse Emulsion

Oil phase added to aqueous phase under high-shear mixing (5000?10000 RPM, 5?10 min). Target size: 1?5 ?m.

Step 4: High Pressure Homogenization

The coarse emulsion passes through the HPH:

Parameter MF59-Type AS03-Type
Pressure 500?800 bar 600?1000 bar
Temperature 2?25 ?C 2?25 ?C
Passes 3?5 3?6
Target size ~ 160 nm ~ 165 nm
Target PDI < 0.15 < 0.15

Step 5: Sterile Filtration

The finished adjuvant is filtered through 0.22 ?m sterile filter.

Step 6: QC Release

  • Droplet size: DLS ? target 150?180 nm
  • PDI: < 0.2
  • pH: Within specified range
  • Endotoxin: < specified limit
  • Osmolality: Within specified range

HPH Equipment for Adjuvant Manufacturing

Scale Smallnm Model Capacity Best For
Lab R&D PTH-10 10 L/h Formulation development
Pilot PTH-20 20 L/h Process optimization, clinical batches
Production 500L/h 500 L/h Commercial manufacturing
Production 1000L/h 1000 L/h Large-scale manufacturing

Key requirements for adjuvant HPH:
– 316L stainless steel wetted parts
– Sanitary / hygienic design
– CIP/SIP capability
– Temperature monitoring and control
– Low pulsation flow
– Smallnm all models meet these standards

Browse Smallnm Homogenizers

Liposomal Adjuvants

Liposomal adjuvants (like AS01) contain immunostimulatory molecules encapsulated in or associated with lipid bilayers. HPH is used in two ways:

  1. Liposome formation: Phospholipids are hydrated and processed through HPH to form unilamellar vesicles (100?200 nm)
  2. Active loading: Immunostimulants are loaded into pre-formed liposomes

HPH parameters for liposomal adjuvants:
– Pressure: 800?1200 bar
– Temperature: Above lipid Tm (typically 40?55 ?C)
– Passes: 5?10
– Size target: 100?200 nm

See also: Liposome Manufacturing by HPH

Quality Control and Regulatory

Critical Quality Attributes (CQAs)

Attribute Method Target
Mean droplet size Dynamic light scattering (DLS) 150?200 nm
PDI DLS < 0.2
Zeta potential ELS >
Squalene content GC-FID ? 10% of target
Tween 80 content HPLC ? 10% of target
pH Meter ? 0.3 of target
Endotoxin LAL < limit
Sterility USP <71> Sterile

Regulatory Considerations

  • HPH is a validated process ? critical parameters (pressure, passes, temperature) are controlled
  • Equipment qualification (IQ/OQ/PQ) is standard for pharmaceutical HPH
  • Smallnm provides documentation packages for validation support

Frequently Asked Questions

Can a high pressure homogenizer be used for vaccine adjuvant production?

Yes. HPH is the standard technology for commercial emulsion vaccine adjuvants (MF59, AS03, and liposomal systems).

What size emulsion droplets are needed for vaccine adjuvants?

The target droplet size for emulsion adjuvants is typically 150?200 nm. This provides optimal surface area for immune stimulation while maintaining injectability and stability.

What pressure is used for adjuvant homogenization?

500?1000 bar for squalene-based emulsion adjuvants. Liposomal adjuvants typically need 800?1200 bar.

Is HPH equipment available for GMP adjuvant manufacturing?

Yes. Smallnm homogenizers are available with sanitary design, CIP capability, and validation documentation for GMP production environments.

What is the composition of MF59 adjuvant?

MF59 is composed of squalene (oil), Tween 80 (surfactant), Span 85 (surfactant), and citrate buffer. The emulsion is produced by high pressure homogenization to ~ 160 nm droplet size.

Internal Links

Smallnm provides high pressure homogenizers for vaccine adjuvant manufacturing ? from lab development to commercial GMP production. CE certified, global support, and validation documentation available.

{ "@context": "https://schema.org", "@graph": [ { "@type": "Organization", "@id": "https://smallnm.com/#organization", "name": "Smallnm", "url": "https://smallnm.com", "logo": { "@type": "ImageObject", "@id": "https://smallnm.com/#logo", "url": "https://smallnm.com/wp-content/uploads/2025/11/cropped-s.png", "contentUrl": "https://smallnm.com/wp-content/uploads/2025/11/cropped-s.png", "caption": "Smallnm", "inLanguage": "en", "width": "512", "height": "512" } }, { "@type": "WebSite", "@id": "https://smallnm.com/#website", "url": "https://smallnm.com", "name": "Smallnm", "publisher": { "@id": "https://smallnm.com/#organization" }, "inLanguage": "en" }, { "@type": "BreadcrumbList", "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#breadcrumb", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "https://smallnm.com", "name": "Home" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/", "name": "Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants" } } ] }, { "@type": "WebPage", "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#webpage", "url": "https://smallnm.com/vaccine-adjuvant-homogenizer/", "name": "Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants - Smallnm", "datePublished": "2026-06-03", "dateModified": "2026-06-03", "isPartOf": { "@id": "https://smallnm.com/#website" }, "inLanguage": "en", "breadcrumb": { "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#breadcrumb" } }, { "@type": "BlogPosting", "headline": "Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants - Smallnm", "datePublished": "2026-06-03", "dateModified": "2026-06-03", "author": { "@type": "Person", "name": "Yves", "url": "https://smallnm.com/author/jkajdmflowo/" }, "publisher": { "@id": "https://smallnm.com/#organization" }, "description": "How high pressure homogenizers are used in vaccine adjuvant production. Covers MF59-like emulsions, AS03-like formulations, liposomal adjuvants.", "name": "Vaccine Adjuvant Production with High Pressure Homogenizer ? Emulsion and Liposome Adjuvants - Smallnm", "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#richSnippet", "isPartOf": { "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#webpage" }, "inLanguage": "en", "mainEntityOfPage": { "@id": "https://smallnm.com/vaccine-adjuvant-homogenizer/#webpage" } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Can a high pressure homogenizer be used for vaccine adjuvant production?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. HPH is the standard technology for commercial emulsion vaccine adjuvants (MF59, AS03, and liposomal systems)." } }, { "@type": "Question", "name": "What size emulsion droplets are needed for vaccine adjuvants?", "acceptedAnswer": { "@type": "Answer", "text": "The target droplet size for emulsion adjuvants is typically 150?200 nm. This provides optimal surface area for immune stimulation while maintaining injectability and stability." } }, { "@type": "Question", "name": "What pressure is used for adjuvant homogenization?", "acceptedAnswer": { "@type": "Answer", "text": "500?1000 bar for squalene-based emulsion adjuvants. Liposomal adjuvants typically need 800?1200 bar." } }, { "@type": "Question", "name": "Is HPH equipment available for GMP adjuvant manufacturing?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Smallnm homogenizers are available with sanitary design, CIP capability, and validation documentation for GMP production environments." } }, { "@type": "Question", "name": "What is the composition of MF59 adjuvant?", "acceptedAnswer": { "@type": "Answer", "text": "MF59 is composed of squalene (oil), Tween 80 (surfactant), Span 85 (surfactant), and citrate buffer. The emulsion is produced by high pressure homogenization to ~ 160 nm droplet size. ---" } } ] } ] }

Tags

#vaccine adjuvant homogenizer

Written by

Related Articles